Comparative biotransformation of morphine, codeine and pholcodine in rat hepatocytes: identification of a novel metabolite of pholcodine

References

• AASMUNDSTAD, T. A., RIPEL, A., BODD, E., BJORNEBOE, A. and MORLAND, J., 1993, Different biotransformation of morphine in isolated liver cells from guinea pig and rat. Biochemical Pharmacology, 46, 961–968.
   PubMed Web of Science ®Google Scholar
• AASMUNDSTAD, T. A. and STORSET, P., 1998, Influence of ranitidine on the morphine-3-glucuronide to morphine-6-glucuronide ratio after oral administration of morphine in humans. Human and Experimental Toxicology, 17, 347–352.
   PubMed Web of Science ®Google Scholar
• BODD, E., DREVON, C. A. and KVESETH, N., 1986, Ethanol inhibition of codeine and morphine metabolism in isolated rat hepatocytes. Journal of Pharmacology and Experimental Therapeutics, 237, 260–264.
   PubMed Web of Science ®Google Scholar
• BUTZ, R. F., JONES, E. C., WELCH, R. M. and FINDLAY, J. W. A., 1983, Pharmacokinetics and O-dealkylation of morphine-3-alkyl ethers in the rat. A radioimmunoassay study. Drug Metabolism and Disposition, 11, 481–488.
   PubMed Web of Science ®Google Scholar
• CASHMAN, J. R., 1999, In vitro metabolism: FMO and related oxygenations. In T. F. Woolf (ed.), Handbook of Drug Metabolism (New York: Marcel Dekker), pp. 477–506.
   Google Scholar
• CHEN, Z. R., BOCHNER, F. and SOMOGYI, A., 1988, Pharmacokinetics of pholcodine in healthy volunteers: Single and chronic dosing studies. British Journal of Clinical Pharmacology, 26, 445–453.
   PubMed Web of Science ®Google Scholar
• CORREIA, M. A., WONG, J. S., SOLIVEN, E., 1984, Morphine metabolism revisited: I. Metabolic activation to a reactive species in rats. Chemico-Biological Interactions, 49, 255–268.
   Google Scholar
• FINDLAY, J. W. A., 1988, Pholcodine. Journal of Clinical Pharmacy and Therapeutics, 13, 5–17.
   PubMed Web of Science ®Google Scholar
• FINDLAY, J. W. A., FOWLE, A. S. E. and BUTZ, R. F., 1986, Comparative disposition of codeine and pholcodine in man after single oral doses. British Journal of Clinical Pharmacology, 22, 61–71.
   Google Scholar
• GONG, Q. L., HEDNER, T., HEDNER, J., BJORKMAN, R. and NORDBER G., 1991, Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3- glucuronide. European Journal of Pharmacology, 193, 47–56.
   PubMed Web of Science ®Google Scholar
• GRANT, M. H., DOOSTDAR, H., MALEY, M., MELVIN, W. T., ENGESET, J. and BURKE, M. D., 1988b, Glucuronidation in rat and human hepatocyte cultures and in human HEP G2 hepatoma cells. In G. Siest, J. Magdalou and B. Burchell (eds), Cellular and Molecular Aspects of Glucuronidation (Paris/John Libbey Eurotext), pp. 129–136.
   Google Scholar
• GRANT, M. H., DUTHIE, S. J., GRAY, A. G. and BURKE, M. D., 1988a, Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell line. Biochemical Pharmacology, 37, 4111–4116.
   PubMed Web of Science ®Google Scholar
• ISHIDA, T., YANO, M. and Tom, S., 1991, In vivo formation of codeinone and morphinone from codeine: isolation and identification from guinea pig bile. Drug Metabolism and Disposition, 19, 895–899.
   PubMed Web of Science ®Google Scholar
• ISHIDA, T., YANO, M. and Tom, S., 1998, In vivo formation of codeinone—glutathione adduct: isolation and identification of a new metabolite in the bile of codeine-treated guinea pig. journal of Analytical Toxicology, 22, 567–572.
   PubMed Web of Science ®Google Scholar
• JOHANSEN, M., RASMUSSEN, K. E. and CHRISTOPHERSEN, A. S., 1990, Determination of pholcodine and its metabolites in urine by capillary gas chromatography. journal of Chromatography-Biomedical Applications, 532, 277–284.
   PubMed Web of Science ®Google Scholar
• JOHANSEN, M., TONNESEN, F. and RASMUSSEN, K. E., 1992, Column-switching high-performance liquid chromatographic detection of pholcodine and its metabolite in urine with fluorescence and electrochemical detection. journal of Chromatography — Biomedical Applications, 573, 283–288.
   PubMed Web of Science ®Google Scholar
• KUMAGI, Y., TODAKA, T. and Tom, S., 1990, A new metabolic pathway of morphine: in vivo and in vitro formation of morphinone and morphinone—glutathione adduct in guinea pig. journal of Pharmacology and Experimental Therapeutics, 255, 504–510.
   PubMed Web of Science ®Google Scholar
• MAURER, H. H. and FRITZ, C. F., 1990, Metabolism of pholcodine in man. Arzneimittel-Forschung, 40, 564–566.
   PubMed Web of Science ®Google Scholar
• MIDHA, K. K., JAWORSKI, T. J., HAWES, E. M., McKAY, G., HUBBARD, J. W., ARAVAGIRI, M., MARDER, S. R., 1991, Radioimunoassay and other methods for the trace analysis of N-oxide compounds. In P. Hlavica and L. A. Damani (eds), N-Oxidation of Drugs (London: Chapman-Hall), pp. 37–55.
   Google Scholar
• MIKUS, G., SOMOGYI, A. A., BOCHNER, F. and EICHELBAU M., 1991, Codeine O-demethylation: rat strain differences and the effects of inhibitors. Biochemical Pharmacology, 41, 757–762.
   PubMed Web of Science ®Google Scholar
• MOLDEUS, P., HOGBERG, J. and ORRENIU S., 1978, Isolation and use of liver cells. Methods in Enzymology, 60–71.
   Google Scholar
• NAGAMATSU, K., OHNO, Y. and IKEBucm, H., 1986, Morphine metabolism in isolated rat hepatocytes and its implications for hepatotoxicity. Biochemical Pharmacology, 35, 3543–3548.
   PubMed Web of Science ®Google Scholar
• OLOFSON, R. A., MARTZ, J. T., SENET, J. P., PITEAU, M. and MALFROO T., 1984, A new reagent for the selective, high-yield N-dealkylation of tertiary amines: improved syntheses of naltrexone and nalbuphine. Journal of Organic Chemistry, 49, 2081–2082.
   Web of Science ®Google Scholar
• PAUL, D., STANDIFER, K. M., INTURRISI, C. E. and PASTERNAK, G. W., 1989, Pharmacological characterization of morphine-6beta-glucuronide, a very potent morphine metabolite. Journal of Pharmacology and Experimental Therapeutics, 251, 477–483.
   PubMed Web of Science ®Google Scholar
• PAWULA, M., SHAW, P. N. and BARETT, D. A., 1994, Determination of codeine and its metabolites in microsomal incubates by high-performance liquid chromatography. Journal of Chromatography B — Biomedical Applications, 653, 106–111.
   PubMed Web of Science ®Google Scholar
• PELANDER, A., OJANPERA, I. and HASE, T. A., 1997, Preparation of N-demethylated drug metabolites for analytical purposes using 1-chloroethyl chloroformate. Forensic Science International, 85, 193–198.
   Google Scholar
• PHILIPSON, J. D., HANDA, J. S. and EL-DABBAS, W., 1976, N-oxides of morphine, codeine and thebaine and their occurrence in Pap aver species. Phytochemistry, 15, 1297–1301.
   Google Scholar
• RADOMINSKA-PANDYA, A., LITTLE, J. M. and CZERNIK, P. J., 2001, Human UDP-glucuronosyltransferase 2B7. Current Drug Metabolism, 2, 283–298.
   Google Scholar
• SETO, Y. and GUENGERICH, F. P., 1993, Partitioning between N-dealkylation and N-oxygenation in the oxidation of N,N-dialkylarylamines catalyzed by cytochrome P450 2B1. Journal of Biological Chemistry, 268, 9986–9997.
   PubMed Web of Science ®Google Scholar
• SVENSSON, J. O., YUE, Q. Y. and SAWE, J., 1995, Determination of codeine and metabolites in plasma and urine using ion-pair high-performance liquid chromatography. Journal of Chromatography-Biomedical Applications, 674, 49–55.
   Google Scholar
• XU, B. Q., AASMUNDSTAD, T. A., BJORNEBOE, A., CHRISTOPHERSEN, A. S. and MORLAND, J., 1995, Ethylmorphine O-deethylation in isolated rat hepatocytes. Biochemical Pharmacology, 49, 453–460.
   PubMed Web of Science ®Google Scholar
• YAMANO, S., TAKAHASHI, A., TODAKA, T. and TOKI, S., 1997, In vivo and in vitro formation of morphinone from morphine in rat. Xenobiotica, 27, 645–656.
   PubMed Web of Science ®Google Scholar
• ZIEGLER, D. M., 1991, Mechanism, multiple forms and substrate specificities of flavin containing mono-oxygenases. In P. Hlavica and L. A. Damani (eds), N-Oxidation of Drugs (London: Chapman-Hall), pp. 59–68.
   Google Scholar